Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Androgen Independent Prostate Cancer”

76 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 76 results

Testing effectiveness (Phase 2)Study completedNCT00350051
What this trial is testing

ZK-Epo Given With Prednisone in Patients With Metastatic Androgen-independent Prostate Cancer

Who this might be right for
Prostate Cancer
Bayer 53
Testing effectiveness (Phase 2)Study completedNCT01487863
What this trial is testing

Concurrent vs. Sequential Sipuleucel-T & Abiraterone Treatment in Men With Metastatic Castrate Resistant Prostate Cancer

Who this might be right for
Prostate Cancer MetastaticHormone Refractory Prostate CancerCastration-resistant Prostate Cancer
Dendreon 69
Early research (Phase 1)Study completedNCT00052000
What this trial is testing

A Trial of MLN2704 in Subjects With Metastatic Androgen Independent Prostate Cancer

Who this might be right for
Prostate Cancer
Millennium Pharmaceuticals, Inc. 29
Testing effectiveness (Phase 2)Study completedNCT00121238
What this trial is testing

Cilengitide in Treating Patients With Prostate Cancer

Who this might be right for
Recurrent Prostate CancerStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 16
Testing effectiveness (Phase 2)Study completedNCT00174863
What this trial is testing

Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Sanofi 232
Testing effectiveness (Phase 2)Study completedNCT00182741
What this trial is testing

Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 19
Testing effectiveness (Phase 2)Ended earlyNCT00471718
What this trial is testing

ABT-751 in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy

Who this might be right for
Prostate Cancer
Vanderbilt-Ingram Cancer Center 27
Not applicableStudy completedNCT00499694
What this trial is testing

Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 31
Large-scale testing (Phase 3)Study completedNCT00436839
What this trial is testing

Taxotere Prostate Cancer New Indication Registration Trial in China

Who this might be right for
Prostatic Neoplasms
Sanofi 228
Early research (Phase 1)UnknownNCT00441571
What this trial is testing

Safety Study of a Radiolabeled Antibody (7E11) in Patients With Progressive Hormone Refractory Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Cytogen Corporation 30
Testing effectiveness (Phase 2)Study completedNCT00072930
What this trial is testing

MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer

Who this might be right for
Prostate Cancer
MedImmune LLC 150
Testing effectiveness (Phase 2)Study completedNCT00849290
What this trial is testing

Immunotherapy For Men With Objective Disease Progression On Protocol D9902 Part B (NCT00065442)

Who this might be right for
Metastatic Androgen Independent Prostate Cancer
Dendreon 113
Testing effectiveness (Phase 2)Study completedNCT00080678
What this trial is testing

Docetaxel With or Without Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases

Who this might be right for
Metastatic CancerProstate Cancer
M.D. Anderson Cancer Center 116
Testing effectiveness (Phase 2)Study completedNCT00258284
What this trial is testing

Capecitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT00715078
What this trial is testing

To Evaluate Sipuleucel-T Manufactured With Different Concentrations of (PA2024) Antigen

Who this might be right for
Prostate Cancer
Dendreon 122
Testing effectiveness (Phase 2)Study completedNCT00068731
What this trial is testing

Lycopene in Treating Patients With Metastatic Prostate Cancer

Who this might be right for
Prostate Cancer
Alliance for Clinical Trials in Oncology 47
Large-scale testing (Phase 3)Study completedNCT00065442
What this trial is testing

Provenge® (Sipuleucel-T) Active Cellular Immunotherapy Treatment of Metastatic Prostate Cancer After Failing Hormone Therapy

Who this might be right for
Prostate Cancer
Dendreon 512
Testing effectiveness (Phase 2)Study completedNCT00070837
What this trial is testing

MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancer

Who this might be right for
Prostatic Neoplasms
Millennium Pharmaceuticals, Inc. 46
Testing effectiveness (Phase 2)Ended earlyNCT00048659
What this trial is testing

YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Who this might be right for
Hormone-Refractory Prostate CancerProstatic Neoplasms
Astellas Pharma Inc
Testing effectiveness (Phase 2)Study completedNCT00569153
What this trial is testing

Safety Study of TAK-700 in Subjects With Prostate Cancer.

Who this might be right for
Prostatic Neoplasms
Millennium Pharmaceuticals, Inc. 123
Load More Results